-
ABEO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Abeona Therapeutics (ABEO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 16.06 mm | 16.06 mm | 16.06 mm | 16.06 mm | 16.06 mm | 16.06 mm |
Cash burn (monthly) | 6.23 mm | (no burn) | 5.12 mm | 5.06 mm | 4.08 mm | 4.06 mm |
Cash used (since last report) | 31.68 mm | n/a | 25.99 mm | 25.73 mm | 20.72 mm | 20.62 mm |
Cash remaining | -15.61 mm | n/a | -9.93 mm | -9.66 mm | -4.66 mm | -4.56 mm |
Runway (months of cash) | -2.5 | n/a | -1.9 | -1.9 | -1.1 | -1.1 |
13F holders | Current |
---|---|
Total holders | 61 |
Opened positions | 15 |
Closed positions | 8 |
Increased positions | 16 |
Reduced positions | 18 |
13F shares | Current |
---|---|
Total value | 180.80 bn |
Total shares | 49.03 mm |
Total puts | 45.00 k |
Total calls | 613.60 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Sco Capital Partners | 11.36 mm | $15.68 mm |
Adage Capital Management | 4.21 mm | $18.44 mm |
Suvretta Capital Management | 3.69 mm | $23.29 bn |
Nantahala Capital Management | 3.43 mm | $21.69 bn |
Adage Capital Partners GP, L.L.C. | 3.25 mm | $20.54 bn |
Millennium Management | 2.30 mm | $14.55 bn |
Integrated Core Strategies | 2.30 mm | $15.03 mm |
Vanguard | 2.01 mm | $12.69 bn |
Vivo Capital | 1.84 mm | $11.65 bn |
Rosalind Advisors | 1.83 mm | $11.58 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 25 | Bernhardt G Zeiher | Common Stock | Grant | Acquire A | No | No | 0 | 36,101 | 0.00 | 47,145 |
31 Jan 25 | Leila Alland | Common Stock | Grant | Acquire A | No | No | 0 | 36,101 | 0.00 | 154,366 |
31 Jan 25 | Faith L. Charles | Common Stock | Grant | Acquire A | No | No | 0 | 36,101 | 0.00 | 149,832 |
31 Jan 25 | Michael Amoroso | Common Stock | Grant | Acquire A | No | No | 0 | 36,101 | 0.00 | 180,466 |
31 Jan 25 | Donald A. Wuchterl | Common Stock | Grant | Acquire A | No | No | 0 | 36,101 | 0.00 | 150,612 |